Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial

Overview of attention for article published in Trials, August 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#25 of 6,365)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 4 news outlets

twitter: 158 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 29 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 206 X posts from 158 X users, with an upper bound of 490,322 followers.

@bollyweed @SHinyoface @AlterIvan1 @lasikeyecenter1 https://t.co/jaPrBgGVNB

Reply Repost Favourite

@Ecccm2Ecccm https://t.co/DTZ2L47WhW https://t.co/Nd8zxYeKaU

Reply Repost Favourite

@milanoIX https://t.co/RE8nJyBc1w

Reply Repost Favourite

@jason_willz1 @rt7683 @markmcdougall13 https://t.co/TzLTIKV62H

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 202 additional X posts.